RetinaRisk is a market-leading brand that offers cutting-edge solutions for diabetic retinopathy care, with the aim of preventing vision loss caused by diabetes. Founded by a team of visionary doctors, this HealthTech company revolutionizes the future of healthcare by providing personalized care based on individualized risk assessment. Their primary focus is on diabetic eye disease, one of the leading causes of blindness that can be prevented in over 90% of cases through early detection.

RetinaRisk offers a range of innovative products and services, including the RetinaRisk iClinic, a web-based clinical decision support service that facilitates easy access to risk management for diabetic eye care and improves screening capacity. They also provide the RetinaRisk mobile app, which empowers users to calculate their personalized risk of sight-threatening diabetic retinopathy, enabling early detection and prevention through timely treatment and lifestyle changes. Additionally, RetinaRisk offers the RetinaRisk API, an application programming interface that allows healthcare providers, clinics, platforms, and insurers to access the RetinaRisk algorithm and provide personalized treatment.

Backed by extensive clinical validation and robust scientific research, RetinaRisk is dedicated to revolutionizing diabetic eye care and ensuring safe and effective preventive measures for patients worldwide